title: Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients?
authors.affiliation: Department of Transplantation Services, Washington Hospital Center, Washington, DC 20010.
authors.forename: N
authors.initials: N
authors.lastname: Khawand
authors.forename: J A
authors.initials: JA
authors.lastname: Light
authors.forename: W
authors.initials: W
authors.lastname: Brems
authors.forename: A
authors.initials: A
authors.lastname: Aquino
authors.forename: A
authors.initials: A
authors.lastname: Ali
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000517:prevention & control*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D007167:Immunotherapy; D016030:Kidney Transplantation; D008875:Middle Aged; D014019:Tissue Donors
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G